BUDGET IMPACT ANALYSIS OF THE USE OF ASPART INSULIN DURING HOSPITALIZATION OF PATIENTS WITH HYPERGLYCAEMIA IN ITALY

被引：0
|
作者：
Iannazzo, S. [1 ]
Pradelli, L. [1 ]
Montagnoli, R. [2 ]
Militano, L. [2 ]
机构：
[1] AdRes HE&OR, Turin, Italy
[2] Novo Nordisk Farmaceut Spa, Rome, Italy
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1327
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A475 / A476
页数：2
相关论文
共 50 条
  • [31] Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart
    Gredal, Charlotte
    Rosenfalck, Anne Mette
    Dejgaard, Anders
    Hilsted, Jannik
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (08): : 739 - 744
  • [32] BUDGET IMPACT ANALYSIS OF THE ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN OBESE PATIENTS IN ITALY
    Viti, R.
    Galvain, T.
    Tong, C.
    Taylor, H.
    Parago, V
    VALUE IN HEALTH, 2019, 22 : S415 - S416
  • [33] Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy
    Belisari, Andrea
    Iannazzo, Sergio
    Di Pasquale, Giuseppe
    Fresco, Claudio
    Mantovani, Lorenzo Giovanni
    Ruggieri, Maria Pia
    Toni, Danilo
    Landolfi, Raffaele
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (02) : 47 - 58
  • [34] BUDGET IMPACT ANALYSIS OF ALECTINIB FOR THE TREATMENT OF PATIENTS WITH UNTREATED ALK-REARRANGED NSCLC IN ITALY
    Bellone, M.
    Pradelli, L.
    Recchia, A.
    Caputo, A.
    Masetti, L.
    VALUE IN HEALTH, 2018, 21 : S28 - S28
  • [35] A budget impact analysis of natalizumab use in Ireland
    A. Dee
    M. Hutchinson
    D. De La Harpe
    Irish Journal of Medical Science, 2012, 181 : 199 - 204
  • [36] A budget impact analysis of natalizumab use in Ireland
    Dee, A.
    Hutchinson, M.
    De La Harpe, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 (02) : 199 - 204
  • [37] BUDGET IMPACT ANALYSIS WITH USE OF SUBCUTANEUS TRASTUZUMAB
    Poquet-Jornet, J. E.
    Carrera Hueso, J.
    Crespo, C.
    Cuesta-Grueso, C.
    Ramon Barrios, M. A.
    Gasent-Blesa, J. M.
    Fortuny-Organs, B.
    VALUE IN HEALTH, 2018, 21 : S27 - S28
  • [38] Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes
    Raskin, P
    Riis, A
    Guthrie, RA
    Jovanovic, L
    Leiter, L
    DIABETES CARE, 2000, 23 (05) : 583 - 588
  • [39] Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy
    Mennini, Francesco Saverio
    Russo, Sergio
    Marcellusi, Andrea
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2012, 13 (03) : 121 - 131
  • [40] BUDGET IMPACT ANALYSIS OF OLAPARIB USE IN PATIENTS BRCA - MUTATED PSROC IN GREECE
    Mylonas, C.
    Aravantinos, G.
    Bamias, A.
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2016, 19 (07) : A720 - A720
12345